Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients

Pediatric Infectious Disease Journal

Volumn 34, Issue 7, 2015, Pages 742-747

  Ringenberg, Theresa ^a   Robinson, Christine ^a,b   Meyers, Rachel ^a,c   Degnan, Lisa ^a,d   Shah, Pooja ^a,d   Siu, Anita ^a,e   Sturgill, Marc ^a,f  

^a RUTGERS UNIVERSITY   (United States)

^b MORRISTOWN MEDICAL CENTER   (United States)

^c SAINT BARNABAS MEDICAL CENTER   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^f RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

neonates; trough; vancomycin

Indexed keywords

CREATININE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BIRTH WEIGHT; BLOOD CULTURE; CONCENTRATION AT STEADY-STATE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FEMALE; GESTATIONAL AGE; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PERINATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; CHEMISTRY; CRITICAL ILLNESS; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NEONATAL INTENSIVE CARE UNIT; SERUM; STAPHYLOCOCCAL INFECTIONS;

ADMINISTRATION, INTRAVENOUS; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RETROSPECTIVE STUDIES; SERUM; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84942837731     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000664     Document Type: Article

References (23)

1. Jain A, Agarwal J, Bansal S,. Prevalence of methicillin-resistant, coagulase-negative staphylococci in neonatal intensive care units: findings from a tertiary care hospital in India. J Med Microbiol. 2004; 53 (Pt 9): 941-944
2. Lessa F, Edwards JR, Fridkin SK, et al. Trends in incidence of late-onset Methicillin resistant Staphylococcus aureus infection in neonatal intensive care units. Pediatr Infect Dis J. 2009; 28: 577-581.
3. Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the guidelines adequate? Arch Dis Child Fetal Neonatal Ed. 2011; 96 (1): F4-F8.
4. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52: e18-55.
5. Young TE,. Mangum B,. Neofax. 22nd ed. Montvale, NJ: Thomson Reuters; 2009: 86.
6. Tenover FC, Moellering RC Jr,. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007; 44: 1208-1215.
7. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66: 82-98.
8. Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009; 28: 398-402.
9. Sakoulas G, Moellering RC Jr,. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis. 2008; 46 (Suppl 5): S360-S367.
10. Dhandi A, Sakoulas G,. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Med Rep. 2012; 4: 4.
11. Moise-Broder PA, Sakoulas G, Eliopoulos GM, et al. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004; 38: 1700-1705.
12. Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006; 166: 2138-2144.
13. Maclayton DO, Suda KJ, Coval KA, et al. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther. 2006; 28: 1208-1216.
14. Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66: 82-98.
15. Chevalier RL, Campbell F, Brenbridge AN,. Prognostic factors in neonatal acute renal failure. Pediatrics. 1984; 74: 265-272.
16. Karlowicz MG, Adelman RD,. Nonoliguric and oliguric acute renal failure in asphyxiated term neonates. Pediatr Nephrol. 1995; 9: 718-722.
17. Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013; 32: e155-e163.
18. de Hoog M, Schoemaker RC, Mouton JW, et al. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther. 2000; 67: 360-367.
19. Badran EF, Shamayleh A, Irshaid YM,. Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital. Int J Clin Pharmacol Ther. 2011; 49: 252-257.
20. Mehrotra N, Tang L, Phelps SJ, et al. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations. Pharmacotherapy. 2012; 32: 408-419.
21. Milsap RL, Jusko WJ,. Pharmacokinetics in the infant. Environ Health Perspect. 1994; 102 (Suppl 11): 107-110.
22. Chawla D, Agarwal R, Deorari AK, et al. Fluid and electrolyte management in term and preterm neonates. Indian J Pediatr. 2008; 75: 255-259.
23. Korres S, Nikolopoulos TP, Komkotou V, et al. Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery. Otol Neurotol. 2005; 26: 1186-1190.